Clinical trial

Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative…

NCT00218244 · National Institute on Drug Abuse (NIDA), NIH · Completed

Key facts

NCT number NCT00218244
Title Using Smokeless Tobacco Products With Lower Nicotine Levels to Reduce Negative Effects of Smokeless Tobacco Use
Official title Treatment of Smokeless Tobacco Users: Use of Nicotine Replacement Products to Reduce Smokeless Tobacco Use
Acronym Brandswitch
Lead sponsor National Institute on Drug Abuse (NIDA), NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Tobacco Use Disorder
Intervention type Other
Interventions Lower Nicotine Smokeless Tobacco Product, Behavioral Counseling
Enrollment 56
Start date Aug 1, 2001
Primary completion Nov 1, 2004
Completion Nov 1, 2004
First posted Sep 22, 2005
Last update posted Jan 10, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies